Segment disclosures

Company overview

VITRO DIAGNOSTICS INC,

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 8 retained observations 4 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operation Segments

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=VTRO:OperationSegmentsMember
PeriodValueUnitFiledEvidence
2026-05-01 – 2026-07-31570464 USD20260918Open filing evidence
2025-11-01 – 2026-07-311546176 USD20260918Open filing evidence
2026-02-01 – 2026-04-30446295 USD20260615Open filing evidence
2025-11-01 – 2026-04-30975712 USD20260615Open filing evidence
2025-05-01 – 2025-07-31608643 USD20260918Open filing evidence
2024-11-01 – 2025-07-311570101 USD20260918Open filing evidence
2025-02-01 – 2025-04-30511584 USD20260615Open filing evidence
2024-11-01 – 2025-04-30961458 USD20260615Open filing evidence